Search - tctmd.com

Displaying 21 - 40 of 50

Sort: Relevancy | Date

News Daily News

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

L.A. McKeown

October 05, 2021

News Conference News EuroPCR 2021

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

Michael O'Riordan

May 19, 2021

News Daily News

‘Aggressive’ OCT Strategy for Stent Sizing Noninferior to IVUS: iSIGHT

Caitlin E. Cox

March 18, 2021

News Daily News

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

Michael O'Riordan

February 04, 2021

News Conference News TCT 2020

IVUS-Guided PCI Gains Support With Longer-Term ULTIMATE Results

Todd Neale

October 15, 2020

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

News Daily News

Better Outcomes, Including Mortality, With IVUS-Guided PCI: Medicare Analysis

Michael O'Riordan

August 18, 2020

News Conference News ACC 2020

PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years

Michael O'Riordan

March 30, 2020

News Daily News

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

Michael O'Riordan

January 17, 2020

News Conference News TCT 2019

IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI

Caitlin E. Cox

October 08, 2019

News Conference News EuroPCR 2019

New Expert Advice on Intracoronary Imaging Urges Shift to Preprocedural Planning

Shelley Wood

May 22, 2019

News Conference News TCT 2018

ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year

Lucy Hicks

September 24, 2018

News Opinion Off Script TCT 2017

Off Script: Focusing on the Future

Kwan S. Lee

October 31, 2017

News Daily News

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Michael O'Riordan

October 11, 2017

News Conference News EAS 2017

Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive

Yael L. Maxwell

May 01, 2017

News Conference News ACC 2017

CARAT: Novel HDL Mimetic Fails to Show Benefit in Coronary Atherosclerosis After ACS

Yael L. Maxwell

March 18, 2017

News Daily News

New Laser-Based Imaging Modality in Development for Atherosclerosis Assessment

Todd Neale

February 17, 2017

News Conference News AHA 2016

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

Michael O'Riordan

November 15, 2016

News Daily News

MILANO-PILOT Falters, Effectively Ending the ApoA-1 Milano Saga

Michael O'Riordan

November 09, 2016

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

Advertisement

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

FUTURE II: A Good ‘First Step’ for Thinner-Strut Bioresorbable Scaffold

‘Aggressive’ OCT Strategy for Stent Sizing Noninferior to IVUS: iSIGHT

Primary PCI Underused but Just as Effective in Cancer Patients With STEMI

IVUS-Guided PCI Gains Support With Longer-Term ULTIMATE Results

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Better Outcomes, Including Mortality, With IVUS-Guided PCI: Medicare Analysis

PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years

Revascularization After PCI or CABG Linked to Higher Mortality: EXCEL

IVUS-XPL at 5 Years Shows Durability of Imaging Guidance in PCI

New Expert Advice on Intracoronary Imaging Urges Shift to Preprocedural Planning

ULTIMATE: IVUS Superior to Angiography at Guiding PCI, With Less TVF by 1 Year

Off Script: Focusing on the Future

Bioresorbable Scaffolds Not to Be Chosen Over DES, Says European Task Force

Plaque Attack: Options Evolve for Imaging Coronaries and Carotids, but Link With Hard Outcomes Remains Elusive

CARAT: Novel HDL Mimetic Fails to Show Benefit in Coronary Atherosclerosis After ACS

New Laser-Based Imaging Modality in Development for Atherosclerosis Assessment

PCSK9 Inhibition and Other New Therapies for Lipid Modification: Good News and Bad

MILANO-PILOT Falters, Effectively Ending the ApoA-1 Milano Saga

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content